Date published: 2026-4-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

BMS 299897 (CAS 290315-45-6)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
γ-Secretase Inhibitor XXIV
Application:
BMS 299897 is a potent γ-secretase inhibitor
CAS Number:
290315-45-6
Purity:
≥98%
Molecular Weight:
511.94
Molecular Formula:
C24H21ClF3NO4S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

BMS 299897 is a potent γ-secretase inhibitor which is noted to inhibit Aβ40 and Aβ42 formation in vitro.


BMS 299897 (CAS 290315-45-6) References

  1. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.  |  Barten, DM., et al. 2005. J Pharmacol Exp Ther. 312: 635-43. PMID: 15452193
  2. Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.  |  Anderson, JJ., et al. 2005. Biochem Pharmacol. 69: 689-98. PMID: 15670587
  3. In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor.  |  Zhang, D., et al. 2006. Curr Drug Metab. 7: 883-96. PMID: 17168689
  4. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.  |  Xue, YJ., et al. 2007. J Pharm Biomed Anal. 43: 1728-36. PMID: 17204392
  5. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.  |  Goldstein, ME., et al. 2007. J Pharmacol Exp Ther. 323: 102-8. PMID: 17640949
  6. Qualitative and quantitative characterization of the amyloid beta peptide (Abeta) population in biological matrices using an immunoprecipitation-LC/MS assay.  |  Ford, MJ., et al. 2008. J Neurosci Methods. 168: 465-74. PMID: 18187205
  7. The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expression.  |  Burton, CR., et al. 2008. J Biol Chem. 283: 22992-3003. PMID: 18574238
  8. Studies on the pharmacokinetics and metabolism of a gamma-secretase inhibitor BMS-299897, and exploratory investigation of CYP enzyme induction.  |  Zheng, M., et al. 2009. Xenobiotica. 39: 544-55. PMID: 19480557
  9. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease.  |  Meunier, J., et al. 2013. Eur J Pharmacol. 698: 193-9. PMID: 23123349
  10. Gamma secretase activity modulates BMP-7-induced dendritic growth in primary rat sympathetic neurons.  |  Karunungan, K., et al. 2023. Auton Neurosci. 247: 103085. PMID: 37031474

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

BMS 299897, 25 mg

sc-358829
25 mg
$265.00